Delivery Order HHSN261201600011I-75N91018F00003

This is a firm-fixed-price delivery order awarded by the National Cancer Institute (NCI) to Miedzynarodowy Instytut Onkologii Molekularnej, a foundation located in Poland. The contract is for Tissue Source Site (TSS) services in support of NCI's Clinical Proteomic Tumor Analysis Consortium, specifically for the analysis of 100 cases across Payments 1-3 at a rate of $2,000 per case (with an 85% payment factor). The total ceiling value of the contract is $402,700. This delivery order is part of...

This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Biomatrix LLC, a woman-owned, Asian-Pacific American-owned limited liability company, for providing a Tissue Source Site (TSS) in support of the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC) program. The contract is a Delivery Order with a Firm Fixed Price valued at $231,228.50. It does not have a set-aside designation and...

This federal contract award is for a Tissue Source Site (TSS) to support the National Cancer Institute's (NCI) Clinical Proteomic Tumor Analysis Consortium (CPTAC) program. The prime contractor, William Beaumont Hospital, doing business as Beaumont Health, is a non-profit hospital that will provide tissue samples for the CPTAC cancer research initiative. The contract has a ceiling value of $3,844.62 and an ultimate completion date of July 14, 2021. It is a firm fixed price delivery order under a...

This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to Biomatrix LLC, a woman-owned and Asian-Pacific American-owned limited liability company, for $348,699.80. The award is for Biomatrix to serve as a Tissue Source Site (TSS) for NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC) program. The contract has a period of performance through April 29, 2019 and does not have a set-aside designation. The CPTAC program is focused on the...

This is a $2,502,392.00 definitive contract awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services (HHS), to Case Western Reserve University to establish a Tissue Source Site (TSS) Network in support of the Cancer Genome Atlas (TCGA) program. The contract has a period of performance through September 30, 2014 and does not have a set-aside designation. The purpose of the contract is to provide clinically annotated biospecimens to the TCGA's...

This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Biopartners, Inc. for the TSS CPTAC DIGITAL MEDICAL IMAGES OF CPTAC BIOSPECIMENS project. The contract has a ceiling value of $12,240.00 and an ultimate completion date of September 17, 2018. It is part of the Tissue Source Site for Tumor Analysis master IDIQ contract. The contract does not have a set-aside designation. The award supports the NCI's Medical Images for CPTAC Biospecimens program.

This is a $15,589.93 firm-fixed-price delivery order awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services (HHS), to Boston Medical Center Corporation (BMC), a non-profit academic medical center in Boston, Massachusetts. The contract is for CPTAC (Clinical Proteomic Tumor Analysis Consortium) task order services and does not have a set-aside designation. The order is part of a larger NCI Tissue Source Site for Tumor Analysis indefinite...

<p>This is a $632,469.60 firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Biopartners, Inc. The contract supports the Tissue Source Site for Tumor Analysis program and has a final completion date of September 4, 2021. There was no set-aside designation for this award. The contract does not mention any major subcontractors.</p>

This is a $98,100.00 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to Asterand US Acquisition Corporation, a for-profit organization. The contract is under the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract vehicle and is set aside for small businesses. The purpose of the contract is to provide tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program. The ultimate completion date for the contract is August...

This is a $15,850.61 firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to the University of Pittsburgh. The contract is part of the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery contract vehicle, and supports the acquisition of tissue samples and data from various types of cancer for the Cancer Genome Atlas (TCGA) program under the American Recovery and Reinvestment Act (ARRA). The contract does not have a set-aside designation. The...